Osteoarthritis of the Knee Clinical Trial
Official title:
Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis
Allogeneic mesenchymal trophic factors (MTF) from human umbilical cord tissue-derived mesenchymal stem cells (UC-MSC) injected into the knee joints of 20 patients (group 1) or injected subcutaneously into 20 patients (group 2) is a safe and useful procedure for inducing joint function improvements in osteoarthritis (OA) patients with grade 2, 3, or 4 radiographic OA severity.
The proposed study will assess primary safety and secondary efficacy endpoints of allogeneic
UC-MSC-derived MTF administered to two arms osteoarthritis patients with grade 2, 3, or 4
radiographic OA severity (20 per arm). The first arm will receive an intra-articular
injection of MTF into the knee joint under fluoroscopy. The second arm will receive 12
subcutaneous MTF injections, once per week.
For both arms, the primary objective of safety will be defined as freedom from treatment
associated adverse events for the period of one year. The secondary objective of efficacy
will include evaluation at baseline and at months 3 and 12 of efficacy endpoints of joint
function improvement as assessed by Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03277066 -
A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis
|
Phase 2 | |
Recruiting |
NCT03090698 -
Outcomes of Injections in Patients Waiting for Total Knee Replacement
|
Phase 4 | |
Completed |
NCT02556710 -
A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT02242435 -
A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis
|
Phase 3 | |
Withdrawn |
NCT02237846 -
Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis
|
Phase 1/Phase 2 | |
Completed |
NCT02096393 -
Patient Specific Instrumentation in TKR
|
N/A | |
Completed |
NCT01849445 -
Targeted Rehabilitation to Improve Outcome After Knee Replacement- A Physiotherapy Study
|
N/A | |
Completed |
NCT01704157 -
A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device
|
N/A | |
Active, not recruiting |
NCT01374230 -
Long-Term Multicenter Evaluation of the E1® Tibial Bearing
|
N/A | |
Completed |
NCT02156440 -
Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee
|
Phase 2 | |
Completed |
NCT01410409 -
Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement
|
N/A | |
Not yet recruiting |
NCT01270412 -
Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis
|
Phase 2/Phase 3 | |
Completed |
NCT01207115 -
A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee
|
Phase 2 | |
Completed |
NCT00988091 -
Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT01331278 -
A Comparative Study of Knee Systems
|
Phase 4 | |
Completed |
NCT00970008 -
Exploring Massage Benefits for Arthritis of the Knee
|
Phase 2 | |
Completed |
NCT00531427 -
Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee
|
Phase 3 | |
Completed |
NCT00792727 -
HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain
|
Phase 3 | |
Completed |
NCT00449696 -
Gel-200 Versus Placebo in Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT04145011 -
Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain
|
N/A |